ClinicalTrials.gg
Drug

Obeticholic acid clinical trials

Also written INT-747 and Ocaliva.

studies test it
36
open now
2
in phase 3
7
first study started
2007

How each study uses obeticholic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the obeticholic acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 May 2016 · OCALIVA · NDA 207999 (FDA, Drugs@FDA)
European Union
12 Dec 2016 · Ocaliva · EMEA/H/C/004093 (EMA; now revoked)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Obeticholic Acid
18
OCA
6
6alpha-ethylchenodeoxycholic acid (6-ECDCA)
6
Obeticholic Acid (OCA)
5
Obeticholic Acid 5 mg
2

Development codes

INT-747
19

Other names

Ocaliva
3
6-ECDCA
2

Studies by the year they started

36 studies that test it; most in 2015 (5)

Studies that test obeticholic acid, by start year
YearStudies
20072
20081
20111
20122
20134
20142
20155
20163
20171
20181
20193
20214
20222
20232
20243

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
19
Phase 3
7
Phase 4
2
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 15

Intercept Pharmaceuticals (17) · GlaxoSmithKline (2) · Sahlgrenska University Hospital (2) · National Cancer Institute (NCI) (2) · Tanta University (1) · King Edward Medical University (1) · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1) · Abhimanyu Garg (1)

Often tested with

Tested in the same studies.

Bezafibrate (2) · Linerixibat (2) · Vitamin E (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test obeticholic acid.

Studies

Open first, then newest update. How each study uses obeticholic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test obeticholic acid →

Codes

What other systems call obeticholic acid · ClinicalTrials.gg INT004470

  • MeSH (NLM) C464660obeticholic acidConfirmed NLM, Wikidata
  • UNII (FDA) 0462Z4S4OZOBETICHOLIC ACIDConfirmed FDA, NLM, Wikidata
  • RxNorm 1798288Confirmed FDA, Wikidata
  • Wikidata Q15708271obeticholic acidConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C80837Obeticholic AcidOne source FDA
  • DrugBank DB05990One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.